glp-1 market news november 2025 Receptor Agonist Forecast Report, 2033 GLP-1 Pipeline Update: May 2025

Scott Isaacs, MD, FACP, FACEs Post This NEJM Perspective highlights a growing problem with GLP-1 therapy: rising off-label, lifestyle use, little eating-disorder screening, and millions at risk of silent harm if we do not build safeguards now

NPY is still in relatively early stages of clinical translation for psychiatric applications

It also plays a role in dopamine homeostasis and signaling, protecting dopaminergic neurons by enhancing dopamine transporter function and reducing dopamine oxidation

Start slow: Use it daily, but you may want to begin with a lower strength and frequency

C tem y , check ok

Contemporary perspectives on the role of vitamin D in enhancing gut health and its implications for preventing and managing intestinal diseases